CNR2 Activators

Activase Activators represent a diverse array of chemical compounds that directly or indirectly catalyze the functional activity of the Activase protein by engaging specific signaling pathways. Beta-caryophyllene and JWH-133 are among the direct agonists which bind to the Activase receptor, triggering G-protein-mediated signaling that results in a decrease in cAMP levels, thereby enhancing the receptor's activity. Similarly, HU-308 and ACPA both act as selective agonists, the former modulating immune response by affecting cAMP production, and the latter activating the PI3K/Akt pathway, which is integral to the receptor's function. GW405833 and Abn-CBD further contribute to this activation ensemble by selectively interacting with Activase, the former by modulating GIRKs and the latter by initiating vasodilatory and immunomodulatory pathways.

On the indirect side, L-α-Lysophosphatidylinositol, while not a direct agonist, may enhance Activase signaling through receptor cross-talk, indicating a complex interplay between different receptor systems. Compounds like serotonin and Palmitoylethanolamide (PEA) indirectly upregulate Activase activity by increasing the availability of endocannabinoids that serve as natural ligands for the receptor, with serotonin affecting the enzymatic degradation of endocannabinoids and PEA inhibiting their breakdown. Anandamide (AEA), an endogenous Activase agonist, binds directly to the receptor, promoting its physiological effects. Collectively, these Activase activators work in concert to potentiate the receptor's signaling, ensuring a robust response to physiological stimuli without altering expression levels or necessitating direct receptor activation.